136 related articles for article (PubMed ID: 8099333)
1. P-glycoprotein-mediated transcellular transport of MDR-reversing agents.
Saeki T; Ueda K; Tanigawara Y; Hori R; Komano T
FEBS Lett; 1993 Jun; 324(1):99-102. PubMed ID: 8099333
[TBL] [Abstract][Full Text] [Related]
2. Human P-glycoprotein transports cyclosporin A and FK506.
Saeki T; Ueda K; Tanigawara Y; Hori R; Komano T
J Biol Chem; 1993 Mar; 268(9):6077-80. PubMed ID: 7681059
[TBL] [Abstract][Full Text] [Related]
3. The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoprotein.
Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K
Jpn J Cancer Res; 2000 Feb; 91(2):248-54. PubMed ID: 10761713
[TBL] [Abstract][Full Text] [Related]
4. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.
Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K
Biol Pharm Bull; 1999 Dec; 22(12):1355-9. PubMed ID: 10746169
[TBL] [Abstract][Full Text] [Related]
5. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.
Ueda K; Okamura N; Hirai M; Tanigawara Y; Saeki T; Kioka N; Komano T; Hori R
J Biol Chem; 1992 Dec; 267(34):24248-52. PubMed ID: 1360010
[TBL] [Abstract][Full Text] [Related]
6. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
Tamai I; Safa AR
J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
[TBL] [Abstract][Full Text] [Related]
7. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
Shirakawa K; Takara K; Tanigawara Y; Aoyama N; Kasuga M; Komada F; Sakaeda T; Okumura K
Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657
[TBL] [Abstract][Full Text] [Related]
8. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
Safa AR; Agresti M; Bryk D; Tamai I
Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
[TBL] [Abstract][Full Text] [Related]
9. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
Friche E; Demant EJ; Sehested M; Nissen NI
Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
[TBL] [Abstract][Full Text] [Related]
10. Differential modulation of P-glycoprotein transport by protein kinase inhibition.
Bates SE; Lee JS; Dickstein B; Spolyar M; Fojo AT
Biochemistry; 1993 Sep; 32(35):9156-64. PubMed ID: 7690250
[TBL] [Abstract][Full Text] [Related]
11. Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug-resistant cells.
Sato W; Yusa K; Naito M; Tsuruo T
Biochem Biophys Res Commun; 1990 Dec; 173(3):1252-7. PubMed ID: 1980066
[TBL] [Abstract][Full Text] [Related]
12. Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma.
Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Akiyama S
Biochem Biophys Res Commun; 1990 Jan; 166(1):74-80. PubMed ID: 1967939
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the azidopine and vinblastine binding site of P-glycoprotein.
Bruggemann EP; Currier SJ; Gottesman MM; Pastan I
J Biol Chem; 1992 Oct; 267(29):21020-6. PubMed ID: 1356986
[TBL] [Abstract][Full Text] [Related]
14. Interaction of digoxin with antihypertensive drugs via MDR1.
Takara K; Kakumoto M; Tanigawara Y; Funakoshi J; Sakaeda T; Okumura K
Life Sci; 2002 Feb; 70(13):1491-500. PubMed ID: 11895100
[TBL] [Abstract][Full Text] [Related]
15. Megestrol acetate reverses multidrug resistance and interacts with P-glycoprotein.
Fleming GF; Amato JM; Agresti M; Safa AR
Cancer Chemother Pharmacol; 1992; 29(6):445-9. PubMed ID: 1348973
[TBL] [Abstract][Full Text] [Related]
16. Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport.
Takara K; Sakaeda T; Kakumoto M; Tanigawara Y; Kobayashi H; Okumura K; Ohnishi N; Yokoyama T
Oncol Res; 2009; 17(11-12):527-33. PubMed ID: 19806783
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
Pascaud C; Garrigos M; Orlowski S
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
[TBL] [Abstract][Full Text] [Related]
18. Effect of PCB-126 on intracellular accumulation and transepithelial transport of vinblastine in LLC-PK1 and its transformant cells expressing human P-glycoprotein.
Sasawatari S; Toki M; Horie T; Nakano Y; Ikeda T; Ueda K; Fujise H
J Vet Med Sci; 2004 Sep; 66(9):1079-85. PubMed ID: 15472471
[TBL] [Abstract][Full Text] [Related]
19. Detection of oligomeric and monomeric forms of P-glycoprotein in multidrug resistant cells.
Poruchynsky MS; Ling V
Biochemistry; 1994 Apr; 33(14):4163-74. PubMed ID: 7908829
[TBL] [Abstract][Full Text] [Related]
20. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H
Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
